Clinical trial
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
NCT04951284
Study timeline
Study start (actual)2021-01-21Date precision: day
Registry last updated2024-06-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Preclinical Alzheimer's Diseaseunresolved
Prodromal Alzheimer's Diseaseunresolved
Alzheimer's Disease (Incl Subtypes)unresolved
Mild Cognitive Impairmentunresolved
Interventions
Sponsors & collaborators
Novoic Limitedlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04951284 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.